Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density

Romosozumab monoclonal antibody treatment works by binding sclerostin and causing rapid stimulation of bone formation while decreasing bone resorption. The location and local magnitude of vertebral bone accrual by romosozumab and how it compares to teriparatide remains to be investigated. Here we an...

Descripción completa

Detalles Bibliográficos
Autores principales: Poole, Kenneth ES, Treece, Graham M, Pearson, Rose A, Gee, Andrew H, Bolognese, Michael A, Brown, Jacques P, Goemaere, Stefan, Grauer, Andreas, Hanley, David A, Mautalen, Carlos, Recknor, Chris, Yang, Yu‐Ching, Rojeski, Maria, Libanati, Cesar, Whitmarsh, Tristan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299688/
https://www.ncbi.nlm.nih.gov/pubmed/34738660
http://dx.doi.org/10.1002/jbmr.4465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299688/
https://www.ncbi.nlm.nih.gov/pubmed/34738660
http://dx.doi.org/10.1002/jbmr.4465

Ejemplares similares